Clinical Trial Update: Randomised Evaluation of Sodium Dialysate Levels on Vascular Events [Phase 4]

View source ↗

Summary

This entry reports a Phase 4 randomized trial evaluating different sodium dialysate levels to assess vascular outcomes in patients with end-stage kidney disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease

Drugs mentioned

• Sodium dialysate with variable sodium concentrations (sodium dialysate)

Snippet

Sponsor: University of Sydney | Conditions: End-Stage Kidney Disease | Phase 4 | Status: RECRUITING